| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.085 | 0.004 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.088 | 0.004 |